• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

R.A.C.E. to Diagnose ALS/MND

A Call to Action to Refer Early Across Diverse Healthcare Settings

R.A.C.E. to Diagnose ALS/MND — Recognize, Assess, Communicate, Expedite — illustration of six healthcare professionals pulling a rope attached to a clock face on a head silhouette, symbolizing the race to diagnose ALS/MND sooner.R.A.C.E. to Diagnose ALS/MND is an education and awareness initiative designed to help healthcare professionals recognize the early signs and symptoms of ALS/MND and support earlier referral and diagnosis.

How can you use the resources?

  • Individual self-study: Use the resources to build your own knowledge and confidence in recognizing possible signs of ALS/MND.
  • Organizational learning: Use the training materials within your organization for education and awareness sessions with colleagues.
  • Faculty-led sessions: Request support from the R.A.C.E. to Diagnose ALS/MND faculty to deliver an education session for your team or organization. Conditions and faculty availability apply. For more information or to book a session, email education@als-mnd.org.
  • Conference and event outreach: Use the program flyer or training materials as part of proactive education and awareness activities at conferences, meetings and other professional events.
  • Online learning: Incorporate the content into existing online education programs and learning platforms.

My Name'5 Doddie Foundation logo

This project was initiated and funded by My Name’5 Doddie Foundation.

Founded by Scottish rugby legend Doddie Weir, My Name’5 Doddie Foundation funds bold ideas, invests in leading researchers, and works to find the fastest routes to treatments and a cure for MND.

On this page:

Learning objectives Resources Videos

Learning objectives

  • Recognize the early signs and symptoms of ALS/MND across diverse healthcare settings and specialties
  • Assess clinical features and initiate appropriate investigations, if warranted, without delaying referral
  • Communicate the need for an urgent onward specialist referral to those with suspected ALS/MND
  • Expedite referrals, even in the absence of complete diagnostic confirmation, and ensure referral letters clearly communicate key clinical findings to support triage

Resources

Download the materials below to use the program, share it with your team or support participants after the training.

PowerPoint Slides (PPTX) — Full slide deck, available to download and adapt to suit your audience

Participant Handout (PDF) — A reference resource for participants, summarizing key information from the content

Program Flyer (PDF) — A two-page, print-ready summary of the R.A.C.E. protocol, key red flags, and how to access the course

Invitation – Virtual Event (PDF) — A ready-to-use invitation template for promoting a virtual educational event

Invitation – Live Event (PDF) — A ready-to-use invitation template for promoting an in-person educational event

Evaluation Form (PDF) — For participants to complete after the session

Speaker Guide (PDF) — Facilitator notes for preparing and delivering the content

Certificate (with speaker) (PDF) — Certificate template that acknowledges the faculty member delivering the session

Certificate (PDF) — Certificate template for participants following session completion

Sign-in Sheet (PDF) — A sign-in template for recording attendance at an educational session

Videos

Watch the full R.A.C.E. to Diagnose ALS/MND program and selected videos exploring diagnostic experiences, referral delays and key clinical considerations.

Faculty Recording of the R.A.C.E. to Diagnose ALS/MND Program

Watch the full faculty-led recording of the R.A.C.E. to Diagnose ALS/MND program.

Person Living with ALS/MND Sharing His Diagnostic Journey

Craig Reyenga, a person living with ALS/MND, shares his challenging diagnostic journey and the difficulties he faced throughout the process.

Your browser does not support embedded video.

Overcoming Therapeutic Nihilism in ALS/MND

Professor Orla Hardiman (BSc, MB, MD, FRCPI, FTCD, MRIA) addresses the misconception that ALS/MND referrals are futile, stressing that multidisciplinary clinics significantly improve quality of life, offer access to research and emerging therapies, and provide meaningful hope for patients.

Your browser does not support embedded video.

The Cost of Delayed Diagnosis: Personal Stories from the Faculty

Members of the faculty present cases they have encountered that highlight the real-world impact of diagnostic delays in ALS/MND.

Professor Orla Hardiman, BSc, MB, MD, FRCPI, FTCD, MRIA

Your browser does not support embedded video.

Ms. Marla Calder, BScOT

Your browser does not support embedded video.

Professor Christopher J. McDermott, PhD, MD, FRCP

Your browser does not support embedded video.

Professor Nortina Shahrizaila, DM, PhD, FRCP

Your browser does not support embedded video.

Recap: When to Suspect ALS/MND and Refer

Professor Nortina Shahrizaila (DM, PhD, FRCP) summarizes key red flags for ALS/MND, such as a progressive, painless loss of motor function or unexplained weight loss with breathing difficulty, and emphasizes the need for immediate referral when symptoms do not fit typical patterns.

Your browser does not support embedded video.

Avoid Diagnostic Pitfalls: Prioritize Urgent Referrals

Professor Orla Hardiman (BSc, MB, MD, FRCPI, FTCD, MRIA) advises non-specialists to refer suspected ALS/MND cases promptly rather than ordering exhaustive tests, noting that early referral prevents delays, reduces unnecessary costs, and ensures patients access specialized evaluation.

Your browser does not support embedded video.

Craig’s MRI Maze: A Journey Through Missed Opportunities and Delayed Referral

Craig Reyenga reflects on his prolonged diagnostic process and how delays left him uncertain about how to live his life and plan for the future, wishing he had been referred to a specialist sooner.

Your browser does not support embedded video.

Faculty Perspective: Frustration with Referral Delays

Professor Christopher J. McDermott (PhD, MD, FRCP) discusses the frustration of receiving late referrals for ALS/MND patients, emphasizing how waiting for diagnostic certainty delays care, support, and access to clinical trials. He urges clinicians to refer early if ALS/MND is even a possibility.

Your browser does not support embedded video.

From Diagnostic Uncertainty to Clarity: Insights from the Voices of People Living with ALS/MND

Two people living with ALS/MND share their journey, describing the impact of not having a diagnosis and how they felt once it was confirmed.

Ms. Leanne Sklavenitis

Your browser does not support embedded video.

Mr. Bruce Virgo

Your browser does not support embedded video.

What If the Patient Asks: “Could This Be ALS/MND?”

Ms. Marla Calder (BScOT) explains how allied health professionals should respond when patients raise concerns about serious conditions — by being honest, supportive, and ensuring prompt referral and clear documentation rather than attempting to diagnose.

Your browser does not support embedded video.

Back to top ↑

Primary Sidebar

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Michel Perrozzo, France

    Michel Perrozzo, France

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • David Solomon, UK

    David Solomon, UK

  • Len Johnrose, England

    Len Johnrose, England

  • Lineke Veenstra, Netherlands

    Lineke Veenstra, Netherlands

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Carlos Alberto Báez Murillo, Colombia

    Carlos Alberto Báez Murillo, Colombia

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Calum Ferguson, Scotland

    Calum Ferguson, Scotland

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Hollister

    Hollister
    hollister

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Chih Ching Darren Wong, Malaysia

    Chih Ching Darren Wong, Malaysia

  • Jean Waters, UK

    Jean Waters, UK

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Art Eggert, USA

    Art Eggert, USA

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Susan Keldani, USA

    Susan Keldani, USA

  • Cassio Fernando da Silva, Brazil

    Cassio Fernando da Silva, Brazil

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login